Reference library

Explore 50 high-interest compounds

Source-backed evidence, safety, regulatory context and trial identifiers. Informational only; not medical advice.

  1. Semaglutide — GLP-1 receptor agonist; evidence: approved use
  2. Tirzepatide — dual GIP/GLP-1 receptor agonist; evidence: approved use
  3. Retatrutide — triple GIP/GLP-1/glucagon receptor agonist; evidence: human RCT
  4. Cagrilintide — long-acting amylin analogue; evidence: human RCT
  5. Cagrilintide + semaglutide blend — unapproved co-formulation/mixture of an investigational amylin analogue and semaglutide; evidence: human RCT
  6. Eloralintide — selective amylin-receptor agonist; evidence: human RCT
  7. Petrelintide — Investigational long-acting amylin analogue; evidence: human RCT
  8. Amycretin (zenagamtide) — Investigational unimolecular GLP-1 and amylin receptor agonist; evidence: human RCT
  9. Pemvidutide — Investigational dual GLP-1/glucagon receptor agonist; evidence: human RCT
  10. Survodutide — dual GLP-1/glucagon receptor agonist; evidence: human RCT
  11. Mazdutide — dual GLP-1/glucagon receptor agonist; evidence: human RCT
  12. Enicepatide (CT-388) — Investigational dual GIP/GLP-1 receptor agonist; evidence: human RCT
  13. Efocipegtrutide — Investigational long-acting GLP-1/GIP/glucagon triple agonist; evidence: other human study
  14. AOD-9604 — synthetic C-terminal human-growth-hormone fragment; evidence: human RCT
  15. HGH fragment 176-191 — C-terminal growth-hormone fragment; evidence: laboratory-only
  16. 5-Amino-1MQ — NNMT-inhibitor research small molecule; evidence: animal
  17. SLU-PP-332 — estrogen-related-receptor pan-agonist research small molecule; evidence: animal
  18. BPC-157 — synthetic 15-amino-acid research peptide; evidence: other human study
  19. TB-500 — identity-ambiguous thymosin-beta-4-related research product; evidence: anecdotal
  20. BPC-157 + TB-500 blend — unapproved multi-peptide blend; evidence: anecdotal
  21. GHK-Cu — copper(II) complex of GHK; evidence: other human study
  22. KPV — alpha-MSH-derived tripeptide; evidence: laboratory-only
  23. GLOW blend — unapproved multi-peptide/copper-peptide blend; evidence: anecdotal
  24. KLOW blend — unapproved four-component peptide/copper-peptide blend; evidence: anecdotal
  25. Thymosin alpha-1 — 28-amino-acid thymic peptide; evidence: human RCT
  26. LL-37 — human cathelicidin-derived antimicrobial peptide; evidence: other human study
  27. ARA-290 — innate-repair-receptor peptide agonist; evidence: human RCT
  28. CJC-1295 without DAC — GHRH analogue listing without drug-affinity-complex modification; evidence: other human study
  29. CJC-1295 with DAC — long-acting GHRH analogue conjugate; evidence: other human study
  30. Ipamorelin — selective ghrelin/growth-hormone-secretagogue receptor agonist; evidence: other human study
  31. CJC-1295 no-DAC + ipamorelin blend — unapproved GHRH-analogue/GHSR-agonist blend; evidence: anecdotal
  32. Tesamorelin — GHRH analogue; evidence: approved use
  33. Sermorelin — growth-hormone-releasing-hormone analogue; evidence: other human study
  34. GHRP-2 acetate — ghrelin/growth-hormone-secretagogue receptor agonist; evidence: other human study
  35. Hexarelin acetate — ghrelin/growth-hormone-secretagogue receptor agonist; evidence: other human study
  36. IGF-1 LR3 — modified insulin-like-growth-factor-1 analogue; evidence: laboratory-only
  37. Somatropin — recombinant human growth hormone protein; evidence: approved use
  38. MOTS-c — mitochondrial-derived 16-amino-acid peptide; evidence: animal
  39. Elamipretide — mitochondria-targeting aromatic-cationic tetrapeptide; evidence: approved use
  40. Epitalon — synthetic tetrapeptide bioregulator; evidence: other human study
  41. Humanin — mitochondrial-derived peptide; evidence: animal
  42. FOXO4-DRI — senolytic research peptide designed to disrupt FOXO4–p53 interaction; evidence: animal
  43. Semax — synthetic ACTH-fragment-derived peptide; evidence: other human study
  44. Selank — synthetic tuftsin-derived heptapeptide; evidence: other human study
  45. Bremelanotide — melanocortin-receptor agonist; evidence: approved use
  46. Melanotan I — alpha-MSH analogue; gray vial identity/presentation not matched to implant; evidence: approved use
  47. Melanotan II — cyclic nonselective melanocortin-receptor agonist; evidence: other human study
  48. Delta sleep-inducing peptide — nonapeptide with unresolved clinically relevant target; evidence: other human study
  49. Kisspeptin-10 — KISS1 receptor agonist decapeptide; evidence: human RCT
  50. Nicotinamide adenine dinucleotide — redox coenzyme/nucleotide; evidence: other human study